Neutersol

From Wikipedia, the free encyclopedia

Neutersol is a brand name for Zinc gluconate (neutralized by Arginine), a compound used to produce infertility in the male dog by chemical disruption of the testicle, intended as an alternative to surgical neutering. Neutersol was developed by Pet Healthcare International, Inc. Neutersol was approved by the U.S. Food and Drug Administration (FDA) for small puppies in 2003.[1] In 2005 however, Pet Healthcare International severed its ties with its manufacturing partner Addison Biologicals, and production of the drug stopped.[2] Neutersol had been expected to be reintroduced into the market by early 2009, but that plan was stalled. Ark Sciences, Inc. now has acquired the intellectual property to this method of sterilization and plans to reintroduce to the US market in 2012 using the safer Esterilsol injection technique used internationally.[3]

Neutersol is contraindicated in cases of cryptorchidism, pre-existing scrotal dermatitis, testicular diseases and malformations, and drug hypersensitivity on Neutersol components.

References

  1. ↑ "FDA Approves Use of Neutersol for Male Puppies". Retrieved 3 January 2010. 
  2. ↑ "Neutersol and Esterilsol: Injectable Sterilization for Male Dogs". Retrieved 3 January 2010. 
  3. ↑ EsterilSol/Neutersol Frequently Asked Questions


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.